These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15326511)

  • 21. Thrombolysis in acute myocardial infarction: current status.
    Kiernan TJ; Gersh BJ
    Med Clin North Am; 2007 Jul; 91(4):617-37; x. PubMed ID: 17640539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International guidelines 2000 for CPR and ECC: what do they mean for you?
    Stapleton ER
    Emerg Med Serv; 2001 Sep; 30(9):45-8. PubMed ID: 11563344
    [No Abstract]   [Full Text] [Related]  

  • 23. Should general practitioners give thrombolytic therapy?
    Drug Ther Bull; 1994 Sep; 32(9):65-6. PubMed ID: 7635040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thrombolytic therapies in the emergency medical services].
    Aaltonen J; Kuisma M
    Duodecim; 2000; 116(10):1110-8. PubMed ID: 11989022
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improved routines in connection with thrombolytic therapy in myocardial infarction].
    Fystro R
    Tidsskr Nor Laegeforen; 1999 Nov; 119(28):4239. PubMed ID: 10668389
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
    MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolytic therapy of ischemic heart disease].
    Ishikawa K
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1621-4. PubMed ID: 9410971
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 32. Canadian Consensus Conference on Coronary Thrombolysis. Recommendations.
    Can J Cardiol; 1993; 9(6):559-65. PubMed ID: 8221355
    [No Abstract]   [Full Text] [Related]  

  • 33. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction.
    Arntz HR; Wenzel V; Dissmann R; Marschalk A; Breckwoldt J; Müller D
    Resuscitation; 2008 Feb; 76(2):180-4. PubMed ID: 17728040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antithrombotics in pre-hospital phase of acute coronary syndromes].
    Collet JP; Dumaine R; Ecollan P; Beygui F; Choussat R; Boon G; Payot L; Montalescot G
    Arch Mal Coeur Vaiss; 2005 Nov; 98(11):1118-22. PubMed ID: 16379108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The GUSTO-V clinical trial.
    Lincoff AM
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():21A-30A. PubMed ID: 11847403
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
    Cannon CP
    Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rural doctor's perspective on the pre-hospital phase of acute myocardial infarction.
    Blattner K
    N Z Med J; 2007 Jun; 120(1256):U2594. PubMed ID: 17589561
    [No Abstract]   [Full Text] [Related]  

  • 40. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
    Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.